Article
Neuregulin-1 and schizophrenia in the genome-wide association study era.
Neuroscience and biobehavioral reviews - 1 Sept 2016
Mostaid Md Shaki, Lloyd David, Liberg Benny, Sundram Suresh, Pereira Avril, Pantelis Christos, Karl Tim, Weickert Cynthia Shannon, Everall Ian P, Bousman Chad A
Abstract excerpt
Clinical and pre-clinical evidence has implicated neuregulin 1 (NRG1) as a critical component in the pathophysiology of schizophrenia. However, the arrival of the genome-wide association study (GWAS) era has yielded results that challenge the relevance of NRG1 in schizophrenia due to the absence of a genome-wide significant NRG1 variant associated with schizophrenia. To assess NRG1's relevance to schizophrenia in...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
